TELA Profile
TELA Bio, Inc. is a commercial-stage medical technology company specializing in advanced solutions for soft-tissue reconstruction. Its focus is on optimizing clinical outcomes by emphasizing the preservation and restoration of anatomical integrity. TELA Bio's flagship product line includes the OviTex Reinforced Tissue Matrix, designed for hernia repair and abdominal wall reconstruction. These products are engineered to enhance patient recovery and improve surgical results through innovative tissue reinforcement technology.
The company also offers the OviTex PRS Reinforced Tissue Matrix, targeting unmet needs in plastic and reconstructive surgery. This product addresses complex surgical challenges by providing a robust solution for reconstructive procedures. Additionally, TELA Bio has developed the OviTex for Laparoscopic and Robotic Procedures, a specialized version of its tissue matrix that incorporates polypropylene fiber and is derived from ovine rumen. This matrix is intended for use in minimally invasive laparoscopic and robotic-assisted hernia repairs, further broadening the company's range of surgical solutions.
TELA Bio markets its products primarily through a dedicated direct sales force, focusing predominantly on the U.S. market. The company’s sales strategy is supported by its in-depth understanding of surgical needs and its commitment to delivering high-quality, effective solutions to healthcare providers. This approach enables TELA Bio to maintain a strong presence in the competitive field of soft-tissue reconstruction.
Founded in 2012 and headquartered in Malvern, Pennsylvania, TELA Bio, Inc. continues to drive innovation in the medical technology sector. The company’s dedication to improving surgical outcomes and enhancing patient care is reflected in its advanced product offerings and ongoing research and development efforts. TELA Bio's strategic focus on soft-tissue reconstruction underscores its commitment to addressing critical clinical needs with cutting-edge solutions.
|
